University of Central Florida

STARS
Honors Undergraduate Theses

UCF Theses and Dissertations

2016

American Agribusiness & Biotechnology: A New Era of Farming
Nicole M. Ryan
University of Central Florida

Part of the American Politics Commons

Find similar works at: https://stars.library.ucf.edu/honorstheses
University of Central Florida Libraries http://library.ucf.edu
This Open Access is brought to you for free and open access by the UCF Theses and Dissertations at STARS. It has
been accepted for inclusion in Honors Undergraduate Theses by an authorized administrator of STARS. For more
information, please contact STARS@ucf.edu.

Recommended Citation
Ryan, Nicole M., "American Agribusiness & Biotechnology: A New Era of Farming" (2016). Honors
Undergraduate Theses. 35.
https://stars.library.ucf.edu/honorstheses/35

AMERICAN AGRIBUSINESS & BIOTECHNOLOGY:
A NEW ERA OF FARMING

by

NICOLE M. RYAN

A thesis submitted in partial fulfillment of the requirements
for the Honors in the Major Program in Political Science
in the College of Sciences
and in The Burnett Honors College
at The University of Central Florida
Orlando, Florida

Spring Term, 2016

Thesis Chair: Dr. Houman Sadri

ABSTRACT
In the past fifty years there has been an incredible amount of change made to the agrarian
system of the United States. New discoveries in the realm of biotechnology led to the adoption of
genetically modified organisms (GMOs) in agriculture and transformed the industry. Due to
regulatory policies set during the nineteen-eighties this technology was able to benefit from
widespread commercialization. Today, we see the effects of this approach and are entering into a
highly volatile political climate with regards to GMOs.
This paper aims to provide an analysis of the regulatory system in place and the
discrepancies that exist in US policy. The factors evaluated through this thesis include the
current US regulatory approach, advancements in biotechnology, and a comparative perspective
on US and EU systems. In each of these reviews it is also relevant to mention consumer opinion
on GMOs and the role of interest groups. It is important for every American consumer to
understand the politics and technology behind their meals. Through the analysis of recent judicial
decisions and the enactment of new laws this thesis explains how the use of GMOs in agriculture
is causing an unprecedented change to the political structures in place.
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INTRODUCTION
The purpose of this thesis is to evaluate the current state of the American agrarian system.
Within the past fifty years we have seen an unprecedented level of change in the way of crop
production. Only fifty years ago a single farmer would produce enough food to feed
approximately twenty-five people. Today, that same farmer can provide for up to 150 people.
The development of agrarian biotechnology is relevant to political scientists due to the potential
for new federal policy to take form. The current regulation of GM substances has not been
updated or changed since its adoption in the nineteen-eighties. We are dealing with a system that
is not only outdated, but rather questionable as well. The inefficiencies in this regulatory process
have paved the way for controversy and public outcry. I believe that within the next twenty-years
this topic will become obsolete. With several of the nation’s more left-leaning states already
taking action, we can expect to see others follow suit. Although I can ensure that this process
will be gradual I do believe that federal intervention will be required. Facing a demand from
consumers and environmentalists alike regulatory agencies will be forced to adopt greater levels
of scrutiny. Ultimately, I foresee a nationwide GM labeling initiative to come as well.
Commonly referred to as “GMOs”, genetically modified organisms have become an
integral part of American farming. In this study I identify today’s current state of industrial
farming as the dependent variable. To explain what has allowed for this evolution of American
agriculture I have chosen to focus on the role of executive policy, and advancements in
technology. Accounting for these two key factors we can better understand the massive changes
seen in American agribusiness. It is also important to emphasize that these developments are not
exclusive to the actual production systems in place, but have impacted the global economy as
1

well. To provide an interesting perspective I will also compare the agrarian system of the United
States with that of the European Union. By raising awareness of the difference in approach these
nations take we will be able to further question the ethicality and safety of genetically-modified
(GM) foods. Besides providing a comprehensive review of American agrobiotechnology I will
also impart what I believe is to come in the future of agrarian biotech regulation.
The focus of this study is to establish how the transition from small family-owned farms
to massive “factory farms” has taken place in a relatively short period of time. To help prove this
point I will target the scientific advancements including the introduction of GMOs and policy
measures that date back to the Reagan Administration. This portion of the thesis will be fact
based and will serve to provide background on the topic for readers. Once these sections have
been completed I will also provide insight into the very tense debate over GM foods. The
controversy surrounding the food industry is quite interesting and I believe it is beneficial to
understand the goals of each side of this argument. The contention over industrial farming is
based on the argument of whether or not GM foods are safe and regulated well-enough.
Recently, the topic of GMOs has been salient among a small portion of the activist public. Those
interested in alternative health lifestyles and environmental advocates are the most vocal about
GM foods. While some argue that GM foods should be eliminated completely from the
American diet others simply push for labeling requirements. Overall it is safe to say that these
groups wish to establish a greater level of transparency among food producers. Within the past
several years activists have made substantial progress in the way of bringing attention to their
cause. In some of the more liberal states, namely California and Vermont, there have even been
ballot initiatives and laws passed to enact mandatory GMO labeling. Without a doubt the topic of
2

GMOs and food safety are current in today’s political atmosphere.
The study and discussion of American agribusiness is relevant to each member of our
society. Unfortunately, the vast majority of the American public is grossly uninformed about the
reality of the food industry. It is likely that much of the public believes that their foods are
produced in the same manner in which they were one-hundred years ago. By understanding how
produce and food-goods reach the super-market consumers will be better adapt to make their
choices.
Due to the sweeping changes that have occurred in the food industry one might expect to
see a regulatory policy that has also seen great change. Through an evaluation of several
prominent federal agencies it can be quickly concluded that this assumption is inaccurate. One
may even be shocked to uncover that there have been absolutely no polices implemented that
specifically regulate GM crops. The several agencies responsible for ensuring consumer food
safety claim that there is no need for new regulations. Further in this study we will evaluate this
claim and establish the rationale behind such executive policy.
Literature Review
In researching agency regulation and biotech trends I have found that there is truly an
overwhelming amount of material on the issue. Due to the lack of new policy measures that have
been implemented older sources on this topic remain surprisingly useful. Considering this
information I have still made a great effort to include mainly sources published within the last
fifteen years.
Over time advancements within the realm of agrobiotechnology have taken place to
improve the GM crops available to producers. Through the writings of one scholar we are able to
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evaluate the advantages in some of the newer GM strains. He goes on to predict that these
developments are likely to result in a competitive global market. What had once began with
simple pest-resistance has resulted in the ability of geneticists to improve even the nutritional
qualities of certain crops. 1The author goes on to explain the increasing level of complexity of
GM strains and their commercial application. Currently the United States is the universal leader
in GMO development and dedicates the greatest amount of resources to this research.
Due to a change in the political atmosphere of the food industry interest groups now have
different methods of achieving their goals. Traditionally, members of these groups were forced
to work through the legislature in order to push their agenda. It is now common for these groups
to use the market the achieve policy change. Due to the legislative route being slow and costly it
can be more practical for interest groups to seek alternative methods. The author describes the
emergence of public interest in the food industry and attributes it to three specific forces. The
congestion of legislative channels, increasing demand from consumers, and the domination of
only a few conglomerates in the food industry are outlined under this study.2 Within the past 50
years this industry and the work of interest groups has changed
dramatically.
The topic of GM foods cannot be discussed without the inclusion of consumer opinion on
the matter. Among consumers there is a much debate over whether or not GMOs are a concern.
While some consumers meet GM foods with uncertainty and fear other embrace the wide-variety
of goods at low prices.3 The authors of this passage go on to quantify what factors make certain
1

Kalaitzandonakes, Nicholas G., “Agrobiotechnology and Competitiveness” American Journal of Agricultural
Economics- Vol 82, No. 5, Dec. 2000, pp. 1224-1233.
2

Schweikhardt, David. & Browne, William. “Politics by Other Means: The Emergence of a New Politics of Food in
the United States”, Review of Agricultural Economics- Vol.23, No. 2, Autumn-Winter 2001, pp. 302-318.
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consumers more concerned with food safety. This study serves as especially useful as it provides
actual consumer experimentation through a unique analytical approach. When breaking down
consumer preferences into data and analytics it is noted that many external factors may affect
one’s opinion on GMOs. This particular study marks the influence of certain demographic
factors and lifestyle choices. The authors even suggest that both a fear of GM foods and a blatant
disregard for them could be representative of the fact that consumers are simply uneducated.
During this thesis I have also chosen to analyze the characteristics of one crop. By far
corn is the most widely-produced crop in the United States. Followed closely by soy and canola,
corn is also the largest GM crop in the nation. In particular a stain of GM corn known as Bt corn,
or Bacillus Thuringiensis corn has been the most popular among producers. This strain has been
the topic of many scholarly articles and serves to help narrow the scope of this study. Although
the implementation of Bt corn can allow for a diminished risk of pest infestation this technology
comes at a cost.4 When purchasing GM seed farmers must determine
whether this greater upfront cost will pay off in the long-run. The Environmental Protection
Agency (EPA) works to evaluate this premium cost and its projected benefit.
Like many other industrialized nations, Canada has a more restrictive policy on the use of
biotechnology than does the United States. Policy network in Canada calls for a split in
regulation between the evaluation of biotechnology and its effect on the environment, as well as
the promotion of its use. Thus, in Canada the commercial influence over biotechnology has a
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Baker, Gregory A. & Burnham, Thomas A. “Consumer Response to Genetically Modified Foods: Implications for
Producers and Policy Makers”, Journal of Agriculture and Resource Economics- Vol. 26, No. 2, Dec. 2001, pp. 387.
4

Hurley, Terrance M., Mitchell, Paul D. & Rice, Marlin E. “Risk and Value of Bt Corn”, American Journal of
Agricultural Economics- Vol 86, No. 2, May 2001, pp. 345-358.
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limit. In the Unites States the policy network in place has allowed for a more permissive
regulation of biotechnology. This difference in regulatory approach between Canada and the
United States reminds of the similar conflict that exists between the US and European Union. 5
This article aims to evaluate the reasoning behind such large policy network discrepancies
and explain the potential effects it may have over time. Although our study aims to compare
US and EU polices regarding GM food I believe that acknowledging Canada’s approach helps
to further prove the United States position as an outlier.
Working to further elaborate on global policy differences it is important to recognize how
biotechnology has been addressed differently in France and the United States. The debate over
the use of biotechnology is central and the transatlantic divide over this issue is reoccurring. The
author uses case studies within the two nations to describe the conflict over regulation of this
engineering. While France has taken deliberate measures to ensure professional regulation of
genetic modification the United States resorts to an industrial method of regulation. 6
These new biotechnical methods of production have emerged only within the last century and
coincide with increased globalization. An interesting topic, the author introduces in his article the
possibility of certain genes to hold a predisposition to cancers, especially breast cancer. While
this article presents highly controversial ideas it makes valid points for its argument. Also worth
mentioning is that over time this difference in policy between nations has grown more tense.
Although I have found value in about every article I’ve read on the topic of agriculture

5

Montpetit, Eric. “A Policy Network Explanation of Biotechnology Policy Differences between the United States
and Canada”, Journal of Public Policy- Vol. 25, No. 3, Sep.-Dec.2005, pp. 339-366.
6

Gaudilliere, Jean-Paul. “Globalization and Regulation in the Biotech World: The Transatlantic Debates over
Cancer Genes and Genetically Modified Crops”, The History of Science Society- 2nd Series, Vol. 21, 2006, pp. 251276.
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and biotechnology, John Hopkins Professor, Adam Sheingate has provided an incredible amount
of insight. Not only do his writings go on to detail the evolution of biotech policy, he does well
in explaining why a “bifurcated policy” exists in American government.7 During this study
several of his articles are used to elaborate on the role of executive policy in shaping today’s
agrarian system. In the United Stated policy surrounding biotechnology supports its use in food
production but condemns that when used in stem cells and cloning. The author evaluates this
discrepancy through analyzing past congressional hearings and the interest of those
present. Interest group influence is a prominent theme in these decisions. The author also
contrasts the policies of the U.S and Europe when it comes to GMOs. Referred to as a
transatlantic divide, the author outlines the ongoing conflict over bioengineering between these
nations. While the U.S. pushes their agenda on the safety and efficiency of GMO products
Europe remains hesitant to adopt these farming techniques.8 Through his articles Dr. Sheingate
highlights each aspect of American agribusiness and emphasizes the significance of the Reagan
Administration at a pivotal moment in GM evolution.
A prevalent conflict between farmers and seed producers, in this case Monsanto, is the
issue of seed-saving. This article outlines the debate over patented seed technology and who
actually own the rights to subsequent seed generations. The issue arises when a farmer uses seeds
that were produced from the seeds of an initial purchase. Seed-saving, a practice commonly used
by farmers for generations is now punishable when applying the first sale doctrine. Monsanto
argues that this act violates their contract and it’s a patent infringement as they own the rights to

7

Sheingate, Adam. “Promotion versus Precaution: The Evolution of Biotechnology Policy in the United States”,
British Journal of Political Science- Vol. 36, No. 2, Apr. 2006, pp. 243-268.
8
Ibid.
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their genetically modified seed. They believe the farmers have not purchased the right to use
these second and third generations of seed. This issue brings up economic concerns for both
parties, however threatens the ability of Monsanto to invest in research and development
programs. Self-replicating technologies such as seed have recently caused great upset in the
realm of agriculture.9 Opponents of GMOs have used landmark cases such as Scruggs v.
Monsanto to win public sympathy and paint Monsanto as the ultimate evil in the GM food
debate. While unfortunate for farmers, the author provides valuable insight into the reasoning
behind the litigation brought by Monsanto.
During the 2012 presidential election California made history as the first state to place a
GM labeling initiative on their ballot. Known as Prop 37, or the Right to Know Genetically
Engineered Food Act, this would have required some degree of labeling on the packages of foods
containing GM additives. 10 Although this item was not passed it did however, receive a great
deal of support from voters state-wide. The proposal was rejected by only a slight margin.
During the campaign multiple chemical engineering firms and consumer-good conglomerates
channeled funds into resistance efforts. Donating over eight-million dollars alone, Monsanto Co.
dominated the campaign. Several others including DOW Chemical Company, DuPont, Pepsi
Co. and ConAgra Foods also supported the opposition to GM labeling through million dollar
donations. Campaigning on the idea that unnecessary labeling would in turn cost consumers
higher prices these companies were able to avoid the passage of Proposition 37. This defeat is
important in the discussion of modern agriculture as we enter a new election period. It is likely
9

Savich, Jason. “Monsanto v. Scruggs: The Negative Impact of Patent Exhaustion on Self-Replicating Technology”,
Berkeley Technology Law Journal- Vol. 22, No. 1, 2007, pp. 115-135.
10

Adler, Jonathan. “How Not to Label Biotech Foods”, The New Atlantis- No. 36, Summer 2012, pp. 37-43.
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that similar amendments will appear of ballots nationwide during the 2016 season.
In researching this topic I have found that finding reliable and unbiased information is
sometimes difficult. I strongly believe that it is important for consumers to be educated on this
subject and therefore aim to present this information free of opinion. While there is ample
information on this subject matter it is fragmented and near impossible to identify a source that is
inclusive of each aspect previously discussed. For instance, journals which have excelled in
outlining the chronology of biotechnology fail to mention the economic implications of these
advancements. My intent is for this research thesis to fill the gap in material available to the
public. Overall, I believe that my final research product will complement the articles and
writings that I have studied.
As mentioned previously, I will also predict where American agribusiness is headed
based on an analysis of recent trends. Through this forecast I will be able to differentiate my
work from that of previous scholars. I believe that this component will be the most exciting and
undoubtedly the most original segment of this thesis.
Research Design
The research and topics outlined in this study will be discussed in five separate chapters.
In the first chapter I have introduced the variables at work and discussed the significance of
studying developments in US agriculture. For the next three chapters I will provide in-depth
evaluations about material I believe to be most critical. The first of these chapters will focus on
the influence of executive policy during the beginning stages of developing biotechnology. Also
in this chapter I will specify the duties of each agency responsible for the regulation of new GM
products. Through the second chapter we will focus on the evolution of agrarian biotech
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applications. In this chapter I aim to cover mainly the scientific aspects of GM foods and the way
in which GM crops benefit producers. During the third explanatory chapter I will compare the
approach taken on GM foods between the United States and the European Union. This
comparative chapter will also allow for speculation into why such divisive policies have formed.
To conclude this study the final chapter will tie together all previously mentioned ideas. I will
include my prediction of where our agrarian system is headed in this final chapter as well.

10

THE REGULATION OF BIOTECHNOLOGY IN AMERICAN POLICY
The regulation of biotechnology has been an interesting topic due to the many
discrepancies that exist in this area. By way of technological advancements in the early 1970’s,
scientists discovered the ability to alter the genetic makeup of species through gene transfer.
These initial experiments were met with great hesitancy from government officials. Over time,
however, the political atmosphere began to warm to the idea of genetic engineering. Likely this
change in attitude could be explained by the realization of profit once these techniques could be
commercialized. During the experimental stages of some of the first genetically modified
organisms (GMOs), it became clear that the regulation of these new species would be needed.
This would eventually lead to the adoption of split regulation under the guidelines known as the
Coordinated Framework for Regulation of Biotechnology. Ultimately, this structure gave
authority to several federal agencies. In particular; The United States Department of Agriculture
(USDA), The Food and Drug Administration (FDA) and the Environmental Protection Agency
(EPA). When evaluating the use of GMOs in agriculture we will focus largely on the role of the
FDA.
An important element to point out is the distinction between biotechnology when used in
agriculture, and that which is used in the medical field. Biotechnology when used for medical
sciences has largely been a source of controversy in the past. Although there has been public
outcry over GMOs in agriculture as well, there has been less focus on this industry. Much of the
American public is simply unaware or lacking education on the topic. When it comes to the
regulation of the biotech industry we are able to see a clear split in policy. This “bifurcated
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policy”11 has been the subject of study for many scholars interested in the field. Through the next
chapter we will evaluate how this policy came to be and the impact it has had on agriculture in
the US.
The Coordinated Framework of Regulating Biotechnology
The Coordinated Framework, which takes a product-based approach to regulation, is
what sets U.S. regulatory policy apart from the process-based approach in Europe. A productbased methodology evaluates only the end result whereas a process-based approach looks at the
way in which something came to be. The outcomes of the Coordinated Framework serve to show
the advantages the executive branch has over Congress when it comes to matters of policy.
While many factors led to the establishment of the Coordinated Framework it was legislation
under the Reagan Administration that ultimately gave way to this system that favored
commercialized interests over public safety. The resulting regulation of the Coordinated
Framework gave the FDA jurisdiction over matters of genetically modified food, food additives,
drugs, and medical devices. The USDA oversaw genetically modified plants, animals and animal
biologics. The EPA was now responsible for only plants genetically modified to have the
properties of a pesticide or micro-organisms intended for non-agricultural uses.
Under the tenants of the Coordinated Framework the FDA was given authority over GM
food substances. This included products intended for human consumption along with livestock
feed. In order to regulate these genetically modified organisms the FDA used the previously
established Federal Food, Drug & Cosmetics Act. Due to the product-based method of regulation
previously discussed many of these newly created organisms were regulated no differently than
11

Sheingate, Adam. “Promotion versus Precaution: The Evolution of Biotechnology Policy in the United States”,
British Journal of Political Science- Vol. 36, No. 2, Apr. 2006, pp. 243-268.
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their non-GM counterparts. For the vast majority of these GM organisms they were able to pass
through the FDA being “generally recognized as safe”, or GRAS, without any substantial
analysis. 12
For as long as a GM product closely resembles an already existing product it will not
undergo scrutiny. Under the FDA’s FD&C Act the following is stated on the topic:
"Under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act (the Act),
any substance that is intentionally added to food is a food additive, that is subject to
premarket review and approval by FDA, unless the substance is generally recognized,
among qualified experts, as having been adequately shown to be safe under the
conditions of its intended use, or unless the use of the substance is otherwise excluded
from the definition of a food additive.”13
This disclosure has caused much concern over the years. Consumers are left to trust the
judgement of an agency who ultimately determines the safety of their foods based on its general
similarity to other organisms.
Another concept that has gone hand-in-hand with the GRAS method is that of substantial
equivalence. The idea of substantial equivalence is much like the product-based GRAS system
we have previously discussed. Under substantial equivalence new plant varieties are to be
evaluated under the previously established regulations and does not provide a thorough analysis
of the new organism. Although the FDA does note that it can be helpful to understand the way a
species came to exist; they focus on the actual product itself.
In a 1992 FDA Federal Register entry the administration goes further into detail to explain what
is meant by these various terms.

12

Acosta, Luis, “Restrictions on Genetically Modified Organisms: United States”. Library of Congress. March
2014.
13

U.S. Food and Drug Administration, “Generally Recognized as Safe (GRAS)”. June 2015.
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“In most cases, the substances expected to become components of food as a result of
genetic modification of a plant will be the same as or substantially similar to substances
commonly found in food, such as proteins, fats and oils, and carbohydrates.”14
Thus, the FDA seeks not to analyze the engineering behind new plant species, but rather serves
to prohibit those that would contain known toxins and harmful substances. Due to the near
identical genetic makeup of many GM and non-GM crops the two are seen as “substantially
equivalent”. While the responsibility to properly regulate falls upon the FDA, producers of GM
plants can be held liable for unsafe products under the agency’s Public Health Service Act. This
extra measure helps to ensure that the foods being put out are safe for consumption. To avoid
being prosecuted for any wrongdoing, producers are able to meet with FDA representatives
before releasing their foods. In theory, the two are able to work together to ensure high standards
for the public.
The United States, in its Coordinated Framework, specifies three principles by which the
regulation of GM foods must take place. The first of these is that the focus is on the actual
product in its end state with disregard to how it was actually produced. The second of these
tenants is that where there is no scientifically established risk a new technology will not be
discounted or barred. Lastly, the framework states that GM foods will be addressed no
differently than those of the same type which are produced through traditional methods.
Bifurcation in Biotech Policy
Due to this division in agencies the jurisdiction of biotechnologies also fell into separate
congressional committees. With this separation of powers in Congress also emerged a bifurcated
policy over biotechnologies, this was the distinction made between agricultural and medical uses.
14

Kesler, David. “Statement of Policy- Foods Derived from New Plant Varieties”. U.S. Food and Drug
Administration. April 1992.
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When it came to biotechnology used for medical research, legislators often had mixed feelings
and took a more precautionary approach. The questionable nature of genetic modification was
and still is much more pronounced in the biomedical realm.
“Scientific breakthroughs in the late 1990s raised additional concerns about the social and
ethical implications of biomedical research. In 1997, researchers in Scotland announced
the successful cloning of a sheep. The following year, an American scientist derived stem
cells from a human embryo for the first time.”15
These advancements in biotechnology and their frightening likeness prompted overwhelming
public concern over whether cloning was ethical in nature. In 2001, President Bush ended federal
funding of research into current stem cell projects. By 2003 the House had effectively banned
any and all forms of human cloning. Through Bush’s presidency many attempts by Congress
were made to loosen restriction on embryonic stem cell research. These efforts were largely of
no prevail as each one was vetoed by Bush.16 Much of the American public remained unsure of
the ethicality surrounding stem cell research and many felt unsettled by the use of human
embryos. In 2008 when Bush completed his second term in office he was replaced by
Democratic Senator Barak Obama. Within only a year of assuming the presidency Obama
reinstated federal funding of embryonic stem cell research by way of executive order. Since this
passing almost a dozen states have passed laws restricting or prohibiting research of this nature.
One of the most interesting aspects of this conflict is the ideological split and polarization
among American political parties on this subject. The Republican Party has largely promoted the
commercialization of agrarian biotech uses and pushed for their approval from the initial
discovery. We can see evidence of this support when the Regan Administration first removed
15

Sheingate, Adam. “Promotion versus Precaution: The Evolution of Biotechnology Policy in the United States”,
British Journal of Political Science- Vol. 36, No. 2, Apr. 2006, pp. 243-268.
16
Ibid.
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regulatory power from the EPA to ensure that GM crops would be more loosely scrutinized.17 It
is reasonable to hold this administration responsible for the popularity of GM crops today. In
hindsight, it is not likely that GM foods would have become so widespread had there been a
Democrat in office. When it comes to biomedical uses of genetic engineering the Republican
Party has been staunchly opposed to furthering research. Though inconsistent, the positions make
sense when considering the Republican platform on free-trade and abortion. On the other hand,
the Democratic Party has taken a cautious approach to the genetic modification of plant species.
The concern of these individuals is that GMOs have not undergone enough testing. Democrats,
who are often more likely to support environmentalism than Republicans, have also expressed
concern over the FDA’s lax regulation. For example, the agency does not require the producers
of GM foods to complete environmental impact statements when releasing new products.
However, it has been the Democrats who have brought forth proposals attempting to expand
stem cell and biomedical research. Each party is guilty of upholding this double standard when it
comes to regulating the use of GMOs.
Consumer Concern over GM Foods
From the very beginning stages of genetic modification many informed consumers have
met this technology with hesitancy. The most promonent activists against the integration of GM
products into our food system are groups promoting consumer safety and the preservation of
environmenal diversity. Most consumers fear GM foods due to a widspread belief that the
longterm consumption of GMOs could result in heath defects. This claim is not based entirey on
science, as many credible sources have reported no concern with the technology. While many of

17

Ibid.
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those in opposition to GMOsencourage an end to their use, they have chosen to instead target
alternative labeling. Inthis labeling effort activist groups have asked grocers and food
conglomerates to label products accordingly when they contain GM ingredients. Due to the
resistance from food producers activist groups have shifted their energy to move state
governments. Through product labeling consumers would be given greater freedom when it
comes to what they allow into their homes and bodies. Today’s current labeling requirements
provide that the attirtributes of the product be detailed but not the method of production. This
measure is a step towards tansperency in an otherwise highly secretive industry. In recent years
this movement has gained great momentum through legislative chanels.
During the 2012 presidential election California had an important ballot initiaive know as
Proposition 37, or the Right to Know Act. If passsed, this law would have mandated the labeling
of GM foods and banned any GM food products from being labeled as “natural”. Opponents of
this act, largely made up of aforementioned conglomerates, argue that this labeling would be
costly and cause undue fear in the minds of consumers.18 Interestingly, the largest campaign
doners for those in opppostion of this act were PepsiCo, Coca-Cola, and Monsanto with each
supplying over one million dollars in funding. In total those in against the passing of this act
donated fourty-eight million dollars, a far cry from the acts supoprters who were able to donate
around nine million.19 When it came to vote Califonia’s Propostion 37 was defeated by a margin
of 2.8% of the vote. Although this act was not made into law the efforts made are not to be
discounted. Those in support of Proppsition 37 were faced with overwhelming odds and
managed to recive almost half the vote from constituents. As an increasing amount of consumers
18
19

Adler, Jonathan. “How Not to Label Biotech Foods”, The New Atlantis- No. 36, Summer 2012, pp. 37-43.
“California Proposition 37, Mandatory Labeling of Genetically Engineered Food (2012)”. BallotPedia.
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begin to look into how their foods are produced it is reasonable to specutalte that if an act like
this were to be put on the ballot again it may have more luck.
As one of the first major initivates to label GM foods for the sake of consumer
empowerment, California’s failed act served as a model for other states. It seems that as
consumers form their own opinion’s on GMOs, the science behind the safety of the technology is
becoming increasinly irrelevant. Feeling pressure from constituents the majority of the U.S. has
propsed labeling initives at their state level.
GMO Food Labeling Initiatives by State
Due to the inefficiencies of current federal regulatory policy, we are seeing a new trend
among many American states. To date, thirty-one of the fifty states have made some effort to
pass GMO labeling laws. The majority of these have used bill proposals as a means of
accomplishing their objectives. While many have been rejected, these initiatives have brought
even greater attention to the issue. The figure below serves to provide a visual representation of
recent state actions. In order to create this chart I individually examined recent bill proposals in
each of the fifty states. Due to the high prevalence of GM labeling bills, it is important to keep in
mind that this data could very easily become outdated in a relatively short period of time. Each
initiative has been proposed within the last four years, and it is unlikely that this rapid rate of
action will slow. The majority of the states, filled in blue, have made an effort to enact a
statewide GM labeling law. None of these states have been effective in their pursuit of labeling
transparency, and many have continued to propose more bills of this nature. Each state that has
been filled in gray has not attempted to label GMOs, nor have they sought to ban this labeling.
The majority of these states lie in the Southern and Midwestern regions of the U.S. The few
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states that have been filled in green are those that have effectively passed laws to label GMOs.
Although these states passed their labeling bills over two years ago, only Vermont has set a plan
of action. Arguably the most interesting aspect of GMO labeling efforts involves the states that
have passed laws banning this labeling. Each state in red has been successful in this approach.

There is no all-encompassing explanation for the distribution of these efforts, and each
state has some degree of variation. It may be helpful to point out the influence of state economic
factors in understanding state action. In several of these red states, namely; Kansas, Michigan,
and Idaho, agricultural products make up a large portion of the state’s economy. It is possible,
accounting for this statistic, that we can better understand the extremely adverse reaction some
states have had to GMO labeling. The opposite can also be said of the green states that have
enacted GMO labeling. In Vermont, Maine, and Connecticut, the state does not heavily rely on
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agriculture to supplement its economy. There is no doubt that the use of GM crops has allowed
food producers and farmers to reap greater rewards. Thinking in terms of self-preservation we
can assume that these red states are out to protect their own economic interests.
State Mandated Labeling Laws (2014-Present)
One of the most important developments for non-GMO activists occurred in 2014 when
the state of Vermont passed the nation’s first labeling law. Signed on May 8 th, 2014 by the state’s
govenor, this initiative differed from GM labeling efforts made in other progressive states.
Instead of placing the issue on ballots like Califorina and Washington had done in the years prior
Vermont opted to create a bill. Although this proposal was passed in 2014 the law is not
scheduled to take effect until June 1st, 2016. The tenants of this law are simalr to that of the
California’s Right to Know Act, as they require the proper labeling of any product containing
GM ingredients and also ban these products from being labeled “natural”. The Vermont law goes
even further as to fine companies if their products are found to be mislabeled. Following the
approval of this bill food producers across the nation began to file suit against the state.20
These groups argue that GM labeling bills are unconsitutional and a threat to their business’s
success.
Last year the United States District Court for the District of Vermont heard a case that
shed light into how courts may decide these controversies. On April 27 th the court decided the
case of Grocery Manufactuers Association v. Sorrell, which resulted in a verdict that largely
supported Vermont’s labeling efforts. The plaintiffs challenge the legality of the madate under
the First Amendment, U.S. Commerce Clause and the Supremacy Clause of the Constituition.
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Under these provisions the GMA alleges that Vermont’s labeling laws are a vioation of free
speech, interefere with interstate commerce, and attempt to supercede federal inspection
criteria.21 Although the court dismissed these complaints, the GMA filed an injuction
to delay the bill from going into effect this June.22 At this point the court continues
to deliberate on the matter and whether this law will remain. It is without a doubt that more
lawsuits of this nature will continue to be brought up. Already two other states, Maine and
Connecticut, have passed similar bills. These measures have received less attention because they
rely on the compliance of several New England area states to also adopt GM labeling laws before
they can take effect. The controversy surrounding labeling laws is especially interesting and will
serve to set precedent for GM labeling across the nation.
The topic of transgenic foods and the policy affecting GM crops is especially current in
today’s political climate. In just about every state there are efforts being made to raise awareness
of consumer food safety and bills being proposed to legislatures. Although it is not likely to
become a point of interest in the next couple of presidntial elections, I see this topic becoming
more mainstream within the decade. In this debate both sides have ground to stand and are able
to provide valid questions about our constiutional rights. As our nation works toward becoming a
more accepting and progessive body it will be interesting to see the future decisions of our
judiciary.
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GENETICALLY MODIFIED ORGANISMS & THEIR PURPOSE
We can trace the introduction of genetically modified organisms back to the Asilomar
Conference held in 1975 in Monterey, California. It was at this assembly that scientists first
introduced their findings that they were able to transfer genes from one organism to another. This
process, which utilized recombinant DNA (rDNA), raised concerns over its potential impact on
the environment and human health. In order to control this new technology the National
Institutes of Health (NIH) created guidelines for the safe handling of organisms resulting from
rDNA experimentation.23 These guidelines, issued in 1976, mark the beginning of biotech policy
in the U.S. One of the many limitations on this experimentation was the prohibition of any
further release of GMOs into the environment. As the development of rDNA transfer and genetic
modification evolved, scientists began to discover a commercial benefit to using their modified
organisms. After the release of several genetically engineered organisms, the need for tighter
regulation became apparent. . Ultimately, it was decided that the regulation of biotechnology and
the introduction of these new organisms fell under the EPA’s Toxic Substances Control Act of
1976 (TSCA).24
While the Reagan Administration was working to promote these biotechnological
advancements, environmentalists and precautionary scientists were working to halt the further
release of GMOs. The growing public concern over the safety of genetically modified organisms,
doubled with an activist-leaning EPA posed a threat to the interests of the Reagan
Administration. As a result if this conflict, the FDA and USDA were given authority to help
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regulate biotechnology by applying their already established statutes on agriculture. Together,
these agencies worked to decide the best possible method of regulation over biotechnology. This
authority, referred to as the Coordinated Framework was published in the Federal Register in
June of 1986.
“The manufacture [through biotechnology] of food, the development of new drugs,
medical devices, biologics for humans and animals, and pesticides will be reviewed by
FDA, USDA, and EPA in essentially the same manner for safety and efficacy as products
obtained by other techniques.”25
Ultimately, once concerns over the introduction of GMOs in agriculture subsided, the legislature
began to see an increase in the amount of hearings discussing the use of biotechnology in the
medical industry.
Understanding the Purpose of GMOs
In recent years the use of GMOs has become prominent in consumer industries. Often
when an organism is modified it is to either; alter the nutrition of a product or, in an effort to
disrupt the agronomic properties. Agronomics refers to the economic balance of promoting the
greatest possible crop yield while preserving high soil quality. This industry has been vastly
broadened within the last fifty years as agrobiotechnology has advanced. Although GM crops are
a relatively new technology the use of these strains has dramatically increased over the past
couple decades. In 1996 less than 4.5 million acres of GM crops were in existence, yet in 2014,
that number had grown to 448 million acres.26 The introduction of GMOs was certainly met
with great hesitancy, however this has not stopped the industry from taking off.
While genetic engineering has been used to improve the nutrition of plant species, the
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most prominent use of biotechnology has been to increase crop yield. Risks such as virus, fungi,
severe weather and pests can drastically affect the survival of a crop. Through various forms
of genetic modification scientists have been able to increase the durability of plant species. When
a crop’s resistance to these threats increase many other factors change as well. Often, a crop will
require less attention and the use of toxic pesticides can be greatly reduced. Other components
such as the irrigation of these crops can also be affected. When a crop requires less dedication
from producers to survive, the overall costs of production are reduced. This process results in a
savings that consumers enjoy at their local grocer. Besides a lesser cost to consumers, GM crops
serve as a more sustainable alternative to traditionally produced agriculture. In this aspect both
producers and environmentalists can count a win.
Due to Europe’s resistance to GM crops, which we will discuss in the following chapter,
several other countries have adopted a cautionary approach to GMOs. Critics of this perverse
attitude see this as being especially detrimental to the lesser developed countries (LDCs). Many
African and South American nations experience starvation and epic rates of chronic hunger
among their people. Allowing for nutrient enriched GM crops to be raised in these LDCs could
result in a great decrease in hunger and related ailments. The United States outperforms the
entire world in terms of agricultural production and this can largely be attributed to GM crops.
With a growing world population it is becoming increasingly important to look for new ways to
sustain human life. Within the next 30 years the global population is expected to reach nine
billion people.27 Scientists have struggled with how we will address this influx and some
have suggested a more widespread use of GMOs. Because many have been lead to be fearful of
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this technology, it will not be an easy feat to implement this system of agronomics on a world
scale. In less than twenty years the use of GM crops has grown astronomically. It is becoming
difficult to find American farmers who chose not to utilize this technology. Following the
cultivation of some of the most prominent GM crops, the graph below shows a drastic increase in
agrarian biotechnology.

A HT crop variety in this graph depicts an organism that is genetically modified to withstand
herbicides. One of the most popular HT plant varieties is Monsanto’s RoundUp® line. These
plants are able to survive a heavy coat of pesticides that would normally kill a non-GM plant.28
In this process any weeds surrounding the crop will be destroyed.
Although most GM crops provide a cost savings, there are cases where the genetic
modification is performed to serve a mere superficial purpose. In 2015 the Arctic Apple, created
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by Okanagan Specialty Fruits, was approved by the FDA to be sold in the U.S. This apple differs
from all others because of its ability to resist natural browning that occurs when being sliced. At
this point only two varieties, Grannie Smith and Golden Delicious, have been approved for
production. We can expect to see these products in grocery stores within the next couple years as
it does take some time to plant and harvest an apple tree. While this particular GM food may not
end world hunger, it certainly solves the issue of having undesirable apples slices on holiday fruit
platters.
Selective Breeding & Transgenic Alteration
A common misconception about GMOs is that this technology has been used for
hundreds, if not thousands, of years. While this statement is not entirely devoid of fact, the truth
of this matter is that hybrid seed are often confused with GM seed. The intention of both
methods are the same-that is, to create a unique plant strain that meets the needs of its creator. In
the case of hybrid seeds farmers cross-breed similar plant species in order to combine the
characteristics of the best plants. The process of hybrid selective breeding is incredibly drawn
out and may take decades before the new traits can be seen. This method has been used by
farmers from the dawn of agriculture and is usually performed through cross-pollination.
Without hybridization and selective breeding many of the fruit and vegetable varieties we know
today would not be in existence, or even suitable for human consumption. The main issue faced
when using selective breeding methods is that the resulting plant species is not able to sustain its
properties.29 Offspring of a hybrid plant are not guaranteed to have the same characteristics as
the parent plant and therefore seed-saving practices are less useful. To combat the dilemmas
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faced when using hybrid seeds scientists were able to manufacture GM seeds that would keep
their properties through each new generation.
GMOs, sometimes referred to as transgenic organisms, are produced through more
advanced methods than selective breeding. In order to attain certain attributes engineers typically
gene splice, combining rDNA from one unrelated species with another. This method has been
incredibly useful in correcting the faults of traditional farming practices. Out of the few GM
crops widely used today the most popular include corn, soybeans, and cotton. Currently, several
types of GM tomatoes and apples have been approved by the FDA, but are produced on a much
smaller scale. As transgenic organisms and the technology used to create these species advances
we can expect to see more types of GM crops in the future.
A Case Study: Bt Corn
Of the various crops produced in the United States annually the largest by a great margin
is corn. While corn is a seemingly innocent side dish on the plates of the American public many
do not realize the multipurpose utility of the crop. From taking a daily vitamin supplement to
drinking a Diet Coke consumers are unknowingly ingesting corn in almost every sitting. Because
of the malleable properties of the grain corn has infiltrated almost every facet of food production.
Corn, in being incredibly inexpensive, has also led to its central role in the diet of nearly every
American consumer. Due to the hearty nature of the plant corn is grown all across the globe,
because it is so widely available costs remain low. Interestingly, although the demand for corn is
high and seemingly infinite the amount of corn being produced is able to match this demand.
Much of the ability of farmers to produce corn in such massive quantities can be attributed to the
growing advancements in technology. Through initial crossbreeding and then genetic
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modification farmers have been able to increase crop yields and even pronounce certain traits.
One of the common strains of GM corn has been named Bt corn, short for Bacillus Thuringiensis
corn.30 As previously explained a GM crop takes one or more traits of another organism through
gene transfer. In the case of Bt corn this gene comes from a bacterium found within soils. In
particular this borrowed gene works to kill the larvae of corn burrowers, which have previously
posed a great threat to farmers. A great benefit among growers of the Bt corn strain is that
farmers are able to use less or eliminate completely the use of pesticides in their production
methods. Due to the highly selective nature of the bacterium only insects of the corn burrower
family are killed. In eliminating the use of insecticides in planting Bt corn strains many other
insects than pose little or no risk are spared. The photo below shows the effectiveness of the Bt
crop in protecting from damage caused by the corn borer.

To the left of this image31are corn cobs produced in traditional, non-GMO methods. The corn
show obvious signs of damage and will be counted as a loss. The right side of this image shows
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DuPont Pioneer’s Optimum Leptra line of Bt corn. This image provides a reader who may not be
familiar with corn borers, with a great visual example of their potential to destroy a landscape.
An interesting observation is made when we examine how exactly Bt corn works. Some
may wonder how it is possible to pinpoint an exact order of insect. The answer is that through
experimentation and extensive laboratory research scientists have been able to target an
endotoxin in the Bt strain. This endotoxin takes action once the corn burrower, most often in the
larvae stage ingests the corn. Once inside the larvae’s stomach cavity the endotoxin begins to eat
away at the stomach walls. Eventually the endotoxin eliminates the stomach walls thus allowing
normal stomach bacteria to enter the larvae’s bloodstream. This outbreak, causing the insect to
go septic, is able to kill the larvae in just hours. 32 While quite a miserable death for corn
burrowers the Bt corn strain does well in protecting the livelihood of the crop along with other
innocent insects.
Cross-Contamination & Seed Saving
A very pressing issue among farmers has been the unintentional spread of GM seed
between neighboring lands. This problem arises when a crop that had been grown without the
use of GM seed becomes pollinated or otherwise contaminated by near-by GM crops. This is
often an issue with the Bt crops strains that typically include cotton, corn and soybean. When a
transfer between crops does take place it is normally harmful to the farmer who raised their crop
without GM seed.33 Organic farming requirements prohibit the use of GMOs in order for a
product to be certified as organic. Cross-contamination between adjacent fields has the potential
to be a financial disaster for organic farmers.
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In order to ensure the integrity of their products Monsanto has developed a coalition of
investigators to monitor famers using their seed. Farmers found in violation of Monsanto’s terms
of use can be sued for contract violations and patent infringements. Being the largest producer of
GM seed, Monsanto has earned an unfavorable reputation among environmentalists. A great
misconception about the company is that they persecute and sue organic farmers based on
inadvertent contamination. This theory is largely unfounded and there are no cases of Monsanto
suing a farmer for only trace amounts of contamination in their crops. Recently, the Organic
Seed Growers and Trade Association attempted to sue the GMO giant under this premise. The
case was overruled and then dismissed on appeal due to the lack of evidence against Monsanto.
While Monsanto has not sought remedies against innocent organic farmers the company
has been successful in cases against users of its seed. A practice known as “seed saving” occurs
when farmers use the seed product from an initial crop to plant and grow a subsequent year’s
crop. While this method has been popular among farmers for centuries, those in contracts with
Monsanto make agreements to refrain from seed saving. Monsanto claims that this new
generation of seed remains patented technology that farmers must purchase. The company serves
as an industry leader in agrobiotechnology and keeps its competitive edge through research and
development projects.
An instance of Monsanto bringing a case against a farmer in an effort to protect this “selfreplicating” technology can be seen in Scruggs v. Monsanto (2007). In this case Monsanto
brought civil charges against a Mississippi cotton farmer, Mitchell Scruggs, and his brother
Eddie. The pair, whom had previously purchased seed from Monsanto’s Roundup Ready® line
were suspected of seed saving and then reselling to third parties. Monsanto alleged that the
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Scruggs brothers made a precise and very intentional decision to violate their contract when they
realized the profit they could incur from resale. In making their defense the brothers attempted to
apply the first-sale doctrine to justify their actions. The first-sale doctrine works to limit the
scope of a copyright or trademark owner by allowing a purchaser to do as they please with a
product post-purchase. The brothers argued that reselling the byproduct of their initial patented
seed purchase fell within the limits of this law. In making their decision the federal court ruled
that the brothers were, in fact, in violation of Monsanto’s terms of use. The first-sale doctrine did
not stand due to the extreme financial consequences it could have on Monsanto’s future sales. By
allowing the Scruggs brothers, and therefore all other farmers, to resell Monsanto seed the court
would have given these farmers a chance to directly compete with the company. 34 In their final
decision the court awarded Monsanto $8.9 million to account for the misconduct of the Scruggs
brothers. To make matters more interesting the brother’s insurance policy holder, Farmland
Mutual Insurance Company was then sued by Mitchell and Eddie Scruggs following this
decision. Refusing to pay the almost nine million dollar settlement, Farmland Mutual stated that
the brothers voided their policy when they decided to intentionally commit wrongdoing against
Monsanto. The court agreed with Farmland Mutual, however; decided not to force the brothers
into paying this remedy. The judge did not see this retribution to be fitting, as the court’s initial
intention was not to “financially ruin” the Scruggs brothers.35 Ultimately, Scruggs v. Monsanto
served to prove the seriousness of infringing on a company’s self-replicating technology and the
measures the courts are willing to take to protect these rights.
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The current events taking place in U.S. federal and state legislatures may be indicative of
future policy. It will be important to watch these actions in the coming decades. With the
majority of U.S. consumers already skeptical of GM foods, there is likely to be an increasing
base behind labeling efforts. As many of the states begin to take on this issue we may see GMO
labeling policies enacted at a federal level.
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A COMPARATIVE PERSPECTIVE ON U.S. & EU AGRICULTURE
Significant differences exist between the regulatory systems governing agriculture in the
United States versus those in the European Union. This distinction is extremely pronounced on
the topic of GMOs but persists through all aspects of agriculture. As we have mentioned
previously, the U.S. has maintained a product-based approach to regulating GM foods. Under the
Coordinated Framework for the Regulation of Biotechnology newly developed GMOs were
passed through the appropriate federal agency. Today’s regulatory system has not seen change
since it was first adopted and all agrarian biotechnology continues to be evaluated under this
framework. Using methods such as GRAS and substantial equivalence new GM products are
typically not thoroughly scrutinized. Typically, unless a product contains a known toxin or
substance harmful to human health, the process by which it was created will not be reviewed.
The risk assessments that do take place in the U.S. are submitted by the producers that create this
technology. Undoubtedly, this raises question over the objectivity of these reports. Overall, the
U.S. largely promotes the use of genetic engineering in agriculture, and keeps relatively relaxed
guidelines in place to ensure their popularity.
The European Union, which consists of twenty-eight Western European countries, takes a much
more precautionary approach on approving agricultural products. It is interesting to note that
both the U.S. and EU initially met agrarian biotechnology with hesitancy. Over time however,
the EU adopted policies that led to a more limited use of GMOs. In order for a GMO to be
approved for cultivation the strain must first pass a thorough risk assessment. To complete this
review both the producer of the crop and the European Food Safety Authority (EFSA) must
publish their own assessment. It is important to note that the EFSA does not regulate GMOs, and
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only makes suggestions on their safety. These assessments test the quality of the proposed
organisms as well as their environmental impact.36 The EU has received a great deal of criticism
for their stricter approach to GM foods. EU leaders defend their process in claiming that a higher
level of scrutiny is necessary to ensure consumer safety and economic integrity. While several of
the EU’s member states have placed a ban on the introduction of GMOs within their borders
other countries in the EU do utilize agrarian biotechnology. The most popular GM crops in
Europe include corn, cotton, and soybean. Through this chapter we will analyze the European
regulatory system in its treatment of agrarian biotechnology and its interaction with US policy.
European Union Member States on GMOs
In the United States there has been some objection to the use of genetic engineering in
food production. Overseas, the attitude towards GMOs is one that is much more staunchly
opposed to their integration into agriculture. In recent years an increasing number of EU member
states have banned the entry of GM laden foods into their borders. The countries that have
approved GMOs, and allowed for the domestic production of GM crops have faced criticism
from their neighbors. In total nineteen of the twenty-eight member states of the EU have decided
not to grow GM crops in their state.37 Although the EU has a much stricter regulatory system
than the US many of these member states are distrusting of the EU’s ability to ensure the safety
of the crops. Public opposition of GMOs is extremely prominent in the EU’s member states.
Consumers have voiced their concern through protests and flamboyant demonstrations. It is not
uncommon for GMOs to be referred to as “Frankenstein foods”, and going as far as calling
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agribusiness firm, Monsanto, a “biotech bully boy”. 38 Still, while the majority of European
consumers are opposed to GMOs the opinion from state to state does vary.
For the duration of this debate over biotech agriculture EU member state, Germany has
remained one the more outspoken over its opposition towards GM foods. The country has
effectively banned the cultivation of GM corn within its borders, and has adopted stricter laws
against GMOs than those that the EU publishes. In 1990 Germany passed its first copy of the
Genetic Engineering Act. This purpose of this act was to protect humans, animals, and the
environment from any unknown risks caused by GMOs. Another important element of this act
was its goal to ensure that both traditionally produced and GM crops would be able to thrive in
the same areas. Lastly, The Genetic Engineering Act established the law and guidelines that
researchers and producers of GMOs would have to abide by. 39 Since its publication Germany’s
act has undergone several revisions in order to comply with EU directives.
Although Germany does keep a very strict cap on the release of GM crops into its environment
the country allows for a limited amount of GM foods and feed into its borders. The majority of
these products are designed for livestock, however, the small amount that are sold to humans are
labeled appropriately under EU guidelines. Germany has taken GMO labeling a step further and
has allowed for a “No Genetic Engineering” label to be placed on qualifying food items. In order
for a product to be approved under this label it must not contain even trace amounts of GMOs.
The country has long held resentment towards GM foods, though arguably the most obvious
example of their opposition comes in the form of their GMO contamination laws. Under German
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law, a party found responsible for the spread of their GM crop onto organic or traditional crops
may be forced to pay hefty damages. Germany’s liability regime also applies to the accidental
pollution of adjacent properties.
“The Act on Genetic Engineering contains a strict liability regime for damage caused by
GMOs. Damages are capped at €85 million (about US$117,050,000), and the operators of
research or production facilities must obtain liability insurance or coverage through
governmental guarantees. Injunctive relief is also available.”40
This policy should not be viewed as typical for all the EU member states as Germany has
remained an outlier in its approach to GMOs. One of the most drastic differences that exists
between the US and EU lies in their perspectives on cross-contamination and the coexistence of
GM and non-GM crops. Issues arising over the accidental contamination of organic or
traditionally produced agriculture by GM crops have been purely a civil dilemma in U.S. courts.
Often, there is no outlet for producers of non-GM crops to seek retributions in the U.S. In fact,
depending on the amount of contamination in an area the farmer negatively affected by this
crossover could be held responsible. Environmentalists have long accused Monsanto of
predatory tactics against farmers; however, stories of farmers being wrongly sued are unfounded.
Tales such as those of the Scruggs brothers are often circulated and lead to misinformation and
fear-mongering.
On the opposite end of the spectrum sits fellow EU member state, Spain, which is the
region’s largest producer of GM crops. Currently, twenty percent of the country’s corn is grown
from GM seed. In several regions of the country where the population of corn borers has been
especially high, the use of Bt corn has been especially helpful in eliminating the majority of
damage caused by these insects. Although European attitudes towards GM crops remain low in
40

Ibid.

36

relation to the rest of the developed world Bt corn has helped to strengthen the Spanish economy.
Transatlantic Divide
The terminology “transatlantic divide” refers to the difference in international political
economies between the U.S. and Western Europe. While this topic covers many differences
between the countries involved we will be focusing only on the aspects that relate to agrarian
biotechnology. There is no question that the approaches taken by the U.S. and EU member states
are almost entirely adverse. For as long as the U.S. has promoted the commercialization of
GMOs the EU has kept a more precautionary attitude. The EU has made efforts to help ease its
members into accepting this new technology, however, many states have refused entirely.
Operating under the European Commission, the European Food Safety Authority (EFSA) helps
to ensure the safety and environmental impact of each newly proposed GMO. The main concerns
addressed through European regulation are like those evaluated in the U.S. Each government
aims to provide a safe and healthy option to both food producers and their consumers.
The root cause of the differences that exist between U.S. and EU regulation come from
the use of product-based and process-based approaches. Earlier we discussed the importance that
the product-based approach, which the U.S. had implemented, ensured the promotion of agrarian
biotechnology. The EU, keeping in line with their precautionary values, chose to enact a processbased approach to regulating transgenic organisms. Along with this approach the EU has placed
an emphasis on the traceability of GM crops. It is the responsibility of famers and food producers
to ensure the accurate measure of a GMO’s supply chain. Ensuring proper traceability has also
allowed for better GMO labeling on consumer products. Throughout the EU products containing

37

more than .09% of a genetically modified substance must be labeled to notify consumers.41 The
European Commission has suggested that applying these labeling methods and traceability
standards help to control any detriments that may arise from the use of GMOs
The Cartagena Protocol on Biosafety
In an effort to regulation the movement of GMO’s to and from different countries, the
Cartagena Protocol on Biosafety to the Convention on Biodiversity was formed. This treaty
among international biotech users, aims to protect organisms natural to the environmental from
being compromised by GM products. The members of the Cartagena Protocol must abide my
precautionary principles, and favor consumer safety over economic gain. Within its supporting
documents the Cartagena Protocol only refers to GM goods as Living Modified Organisms
(LMOs).42 At this point in time the assembly is made up of 170 parties and went into effect in
2003. This figure includes each member state of the EU, as well as developing countries around
the world. The fact that the U.S. is not a party to this treaty has been pointed out and questioned
in the past. It truly is odd that nation’s such as Cambodia and Afghanistan have taken a stronger
interest than the U.S. in investigating the safety of GMOs. However, when considering the
American interest in promoting the productivity of their agrarian economy this absence becomes
clear.
An issue that has arose from the U.S.’s refusal to participate in the Cartagena Protocol on
Biosafety centers on trade.43 Ultimately, the tenants of this treaty greatly affect the quality of
goods that parties are able to take in. The inability of U.S. producers to ensure an accurate line of
traceability in their exports has been detrimental. Many countries have decided to reject U.S.
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agrarian imports because of the inability to determine the genetic makeup of the organism. With
the presence of harsh cross-contamination laws in the EU, countries are now hesitant to accept
GMOs from overseas.
The divide between the EU and U.S. in regard to agricultural and biotechnology
continues to be a contentious debate. The relative absence of corporate interests within the
European system of policy is likely to have played a part in the difference between the two
bodies. The U.S. was quick to prioritize its own economic wealth, whereas the EU sought to only
pass GM legislation when it felt entirely confident in the technology. U.S. politics have long
included the influence of corporate interest in policy making, a trend that is not apparent in EU
politics. As American consumers push for a regulatory system that models that of the EU, we
may begin to see a coming together on this issue between the two.
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CONCLUSION
The topic of agrarian biotechnology is an incredibly relevant topic in the life of every
American consumer. In only thirty short years this technology has become so widespread that
GMOs have now become an integral part of our daily diets. The utilization of GMOs in farming
has undoubtedly transformed the industry and allowed for drastic increases in productivity. By
adopting a product-based regulatory approach the U.S. was able to capitalize on this unharnessed
technology. Ultimately, the U.S. was able to secure its place as a top agricultural producer and
continues to dominate the economy today.
The influence of corporate interests the creation of U.S. policy is very prevalent when
comes to regulating transgenic organisms. The ability of private interests and multinational
corporations to sway policymakers is questionable in its very nature. From the early stages of its
creation the Coordinated Framework had already failed its people. This attempt to provide
standards for evaluating GM foods was a Band-Aid solution that should have been dissolved
decades ago. To date there have been absolutely no efforts made by the USDA or the FDA to
conduct independent research on the safety of GM goods. This policy is outdated and only serves
to mask the inefficiencies of current federal regulation. Whether or not an individual believes
GMOs to be a cause for concern is irrelevant. A greater level of care for consumer health and
general transparency needs to be installed within our federal agencies.
Future Research
Through completing this research I feel that I have provided a foundation on which to
launch future projects. In my efforts to be all-encompassing of this topic I feel there are many
different directions that I may be able to go next. The following are several ideas that I feel
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would make interesting research topics:
One future study I would enjoy completing would be to provide a more in-depth analysis
of only the state actions taking place. During the time I spent creating the color map I realized
the great amount of diversity in each state’s proposals. For example, in both of the Carolinas the
bill proposals focused exclusively on the labeling of GM dairy products. I found this to be
interesting, as no other states mentioned the GM-contamination of animal products. Many of the
states who did attempt to pass GMO labeling legislation were not successful. I believe it would
be interesting to further examine the tenants of these state’s bills and uncovered why they were
rejected. I established some degree of correlation between GMO labeling actions and the
economies of their state. Namely, I discussed the relation between states with a strong
dependence on agriculture and the laws passed to actually ban GMO labeling. A difficulty in
executing a study of this nature is the constantly changing actions of legislatures. Due to the
relevance and popularity of GMO labeling work it may be a challenge to remain current.
A separate research topic could allow for a greater emphasis on the environmental
impacts of industrial farming methods. Environmental law NGOs have become increasingly
popular and now serve a vital role in policymaking. With an ever increasing global population it
may not be possible for other nations to uphold their precautionary approach to GMOs. The
destruction of animal habitats and the exploitation of natural resources are already important
issues. Another aspect of this study may involve assessing the effects of consumerism on
agricultural demand. This topic also relates to environmental issues associated with agriculture.
While this may be less important to the study of political science, I believe this evaluation would
serve to be useful. Facing the need to produce at a higher rate than ever before, our environment
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could take a devastating hit. Agriculture and animal rearing are the greatest contributors to
deforestation and pollution. Although many environmentalists will not admit, GM crops are
more sustainable methods of farming than mass produced non-GM crops. This is especially true
for the Bt and Ht strains that we have previously discussed. Their abilities to resist pests and
herbicides also allow for decreases in water consumption. It will be interesting to see the
outcome of policy over the next couple decades, and what the future holds for GM crops.
Lastly, a third related study could assess consumer knowledge of transgenic organisms
and their regulation. Through the duration of this study I have encountered many friends and
family members who hold strong feelings toward GMOs. Many of these friends are then unable
to provide any knowledge of what this technology truly is. Without a doubt, the general public
is even less educated on their nation’s government. I believe that it would be interesting to
conduct a survey that would be telling of an individual’s knowledge of this topic. Due to the
large role of consumers and activist groups in labeling efforts, this could provide insight into
their rationale. This survey could be implemented in a variety of different ways; however, it may
be best to utilize Qualtrics for better accessibility and ease. In order to properly gauge consumer
awareness, this assessment could provide a variety of questions at different difficulty levels.
Some of the items that could be included are as follows:


What does the acronym GMO stand for? Low Level



Which states, if any, have passed GMO labeling requirements for producers? Mid-Level



What are the top three most widely-produced GM crops? High-Level

Once date collection had taken place, an assessment of each participant’s level of knowledge
could be noted. At the end of the study the average degree of consumer knowledge could be
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computed. To make this study more interesting the survey could also ask the individual to
estimate their own awareness, along with their level of concern for GMOs. The results of this
study would allow the researcher to draw correlations, if any, between passion for GM labeling
and their level of knowledge on the topic.
I strongly believe that each of these projects would help to supplement the research that
I have conducted. The issues and various topics that involve agriculture and its economic
influence are far-reaching. In the past, studying agriculture may have been restricted to biologists
and economists. Today, we see the importance of understanding agrarian regulatory policy more
than ever before. The changes that take place over the next couple decades will certainly
influence the international political economy of the U.S.
Trends & Expectations
I cannot stress enough the importance of future regulatory policy over the use of GMOs.
There is no doubt that structural changes will be made to the Coordinated Framework within the
next twenty years. Depending of the route that U.S. policymakers seek out, the outcomes of new
policy implementation could go in more than one direction.
In this first scenario we will assume that the U.S. government adopts a precautionary
approach to regulating GMOs. This would involve regulating new transgenic organisms through
a process-based system, and likely stalling the immediate release of new GMOs. State GMO
labeling initiatives would become irrelevant once federal labeling laws were passed. This
legislation would end the ongoing debate over the labeling of GM foods, and would require that
the court system support the labeling laws. After the U.S. began to abide by these precautionary
standards, it would be able to join the Cartagena Protocol on Biosafety. By participating in the
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Cartagena treaty any trade issues that the U.S. had experienced with other nations would be
resolved. This method would be favorable to consumers who wish to see a stricter level of
scrutiny, and greater transparency in the industry. The possible negative implications of this
method could involve the economic loss experienced by agricultural producers and food group
conglomerates. These multinational corporations would suffer the greatest loss as a result of the
precautionary principle. It is unlikely that this policy would cause the U.S. to sacrifice its role as
a global leader in agriculture. Stripping farmers from their right to access GM crops would also
result in great upset and possible lawsuits over the First Amendment. Considering these
consequences I believe that this course of action would benefit the U.S. and its consumers the
most.
The alternative to the previous situation would involve the refusal of executive
intervention, and the failure to pass any new policies regarding GMOs. The federal government
would allow for states to handle their own agriculture and the labeling of GM substances. This
inaction would result in the continuation of debate over GMOs and their labeling. Keeping the
Coordinated Framework in place, the U.S. would experience the same disconnect from the EU
and its allies that it does presently. Over time it is likely that this difference in policy would grow
more tense. Neither consumer nor producers of GMOs would ultimately benefit from this
approach. Due to the controversy over GMOs it is almost necessary for the federal government
to step in and end the debate. The self-regulation of agrobiotechnology firms, like Monsanto and
DuPont, is no longer seen as an effective form of policy. In order to provide an unbiased
evaluation of each new organism, independent research should be conducted.
No matter the outcomes of federal policy in the future, we may expect to see a change in
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the popularity of GM crops. Agriculture relies on the demand of the consumers, and when large
classes of people begin to avoid a product its only logical that companies adjust. Similar to the
U.S. government, even private organizations exist for their people.
Closing Remarks
Entering this study I worried that my opinions may cloud my ability to provide an
accurate portrayal of the industry. The issues surrounding the regulation of biotechnology are
controversial and questionable. Through the duration of this research I began to see the rationale
behind each side of this argument. The policy aspect of agrobiotechnology is what I have found
to be most interesting, and I am excited to see the future legislation that will replace the
Coordinated Framework. The state action resulting from federal inactivity is a compelling part
of the case for GM labeling. It has never been more clear that a new policy approach to GMOs is
necessary.
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